DE69840674D1 - Substituierte cyclopentan- und cyclopenten-verbindungen als neuraminidase-blocker - Google Patents

Substituierte cyclopentan- und cyclopenten-verbindungen als neuraminidase-blocker

Info

Publication number
DE69840674D1
DE69840674D1 DE69840674T DE69840674T DE69840674D1 DE 69840674 D1 DE69840674 D1 DE 69840674D1 DE 69840674 T DE69840674 T DE 69840674T DE 69840674 T DE69840674 T DE 69840674T DE 69840674 D1 DE69840674 D1 DE 69840674D1
Authority
DE
Germany
Prior art keywords
cyclopenten
neuraminidase
blocker
compounds
substituted cyclopentane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69840674T
Other languages
English (en)
Inventor
Yarlagadda S Babu
Pooran Chand
John A Montgomery
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocryst Pharmaceuticals Inc
Original Assignee
Biocryst Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocryst Pharmaceuticals Inc filed Critical Biocryst Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69840674D1 publication Critical patent/DE69840674D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C07C247/14—Compounds containing azido groups with azido groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
DE69840674T 1997-12-17 1998-12-17 Substituierte cyclopentan- und cyclopenten-verbindungen als neuraminidase-blocker Expired - Lifetime DE69840674D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6995697P 1997-12-17 1997-12-17
US8525298P 1998-05-13 1998-05-13
PCT/US1998/026871 WO1999033781A1 (en) 1997-12-17 1998-12-17 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors

Publications (1)

Publication Number Publication Date
DE69840674D1 true DE69840674D1 (de) 2009-04-30

Family

ID=26750600

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69840674T Expired - Lifetime DE69840674D1 (de) 1997-12-17 1998-12-17 Substituierte cyclopentan- und cyclopenten-verbindungen als neuraminidase-blocker

Country Status (28)

Country Link
US (1) US6562861B1 (de)
EP (1) EP1040094B9 (de)
JP (3) JP4102022B2 (de)
KR (1) KR20010024743A (de)
CN (1) CN1282316A (de)
AR (1) AR016162A1 (de)
AT (1) ATE425955T1 (de)
AU (1) AU2200199A (de)
BE (1) BE2018C032I2 (de)
BR (1) BR9813480A (de)
CA (1) CA2315262C (de)
CY (2) CY1109153T1 (de)
DE (1) DE69840674D1 (de)
DK (1) DK1040094T3 (de)
ES (1) ES2324746T3 (de)
FR (1) FR18C1037I2 (de)
HU (1) HUP0100142A3 (de)
IL (1) IL136812A0 (de)
LT (1) LTC1040094I2 (de)
NL (1) NL300952I2 (de)
NO (1) NO20003084L (de)
PL (1) PL196674B1 (de)
PT (1) PT1040094E (de)
RO (1) RO121815B1 (de)
SI (1) SI1040094T1 (de)
SK (1) SK8712000A3 (de)
WO (1) WO1999033781A1 (de)
ZA (1) ZA9811595B (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2263179T3 (es) 1996-06-14 2006-12-01 Biocryst Pharmaceuticals Inc. Compuestos de clopentano sustituido como inhibidores de la neuraminidasa.
RO121815B1 (ro) * 1997-12-17 2008-05-30 Biocryst Pharmaceuticals, Inc. Derivaţi pentaciclici substituiţi, compoziţie farmaceutică ce îi conţine şi utilizarea acestora ca inhibitori de neuraminidază
JP2002521312A (ja) * 1998-04-23 2002-07-16 アボット・ラボラトリーズ ノイラミニダーゼの阻害剤
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
WO2000028328A1 (en) 1998-11-05 2000-05-18 Biocryst Pharmaceuticals, Inc. New cyclopentane and cyclopentene compounds and use for detecting influenza virus
WO2001000558A1 (en) * 1999-06-28 2001-01-04 Biocryst Pharmaceuticals, Inc. Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates
KR20020022727A (ko) * 1999-06-28 2002-03-27 다우 케네드 제이. 치환된 시클로펜탄 유도체들과 그것의 새로운 결정구조를만드는 제조 공정
WO2001001569A2 (en) * 1999-06-28 2001-01-04 Ortho-Mcneil Pharmaceutical, Inc. Process for preparing (-)-(1s,4r) n-protected 4-amino-2-cyclopentene-1-carboxylate esters
US6762316B1 (en) * 1999-06-28 2004-07-13 Biocryst Pharmaceuticals, Inc. Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
US6627396B1 (en) 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
WO2001062242A1 (en) * 2000-02-24 2001-08-30 Biocryst Pharmaceuticals, Inc. Prodrugs of substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
CA2397661C (en) * 2000-03-01 2012-01-03 Janssen Pharmaceutica N.V. 2,4-disubstituted thiazolyl derivatives
AU2001252578A1 (en) * 2000-04-25 2001-11-07 Sankyo Company Limited Preventives for influenza
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
EP1334969A4 (de) * 2000-10-18 2005-08-24 Kuraray Co VERFAHREN ZUR HERSTELLUNG VON 4-N-SUBSTITUIERTEN AMINO-2-AZA-1-OXABICYCLOç3.3.0!OCT-2-EN-6-CARBONSÄUREESTERN UND VERFAHREN ZUR HERSTELLUNG IHRER ZWISCHENPRODUKTE
WO2002092555A1 (fr) * 2001-05-11 2002-11-21 Sankyo Company, Limited Derives d'acides sialiques
ES2401285T3 (es) * 2004-12-16 2013-04-18 The Regents Of The University Of California Fármacos con el pulmón como diana
WO2007087056A2 (en) * 2006-01-13 2007-08-02 Scolr Pharma, Inc. Peramivir derivative for oral administration
US20070203241A1 (en) 2006-02-13 2007-08-30 Babu Yarlagadda S Antiviral treatments
KR102323339B1 (ko) * 2006-02-13 2021-11-08 바이오크리스트 파마수티컬즈, 인코퍼레이티드 정맥내 항바이러스 치료
MX2008013140A (es) * 2006-04-12 2009-02-12 Biocryst Pharm Inc Tratamientos antivirales intramusculares.
US20070244193A1 (en) * 2006-04-12 2007-10-18 Babu Yarlagadda S Intramuscular antiviral treatments
CN100432047C (zh) * 2006-07-03 2008-11-12 华南农业大学 一种抗流感及禽流感病毒药物帕拉米韦的合成方法
US8227425B2 (en) 2007-01-23 2012-07-24 Therapicon Srl Antiviral compounds
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
EP2540726B1 (de) * 2007-08-02 2019-10-09 Millennium Pharmaceuticals, Inc. Zwischenprodukte zur Synthese von E1-aktivitätsaktivierenden Enzymhemmern
CN101367750B (zh) * 2007-08-14 2012-05-23 中国人民解放军军事医学科学院毒物药物研究所 (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途
AU2014200052B2 (en) * 2007-11-05 2016-01-07 Ala Wai Pharma, Inc. Formulations for enhanced bioavailability of orally administered polar agents
AU2008324787B2 (en) * 2007-11-05 2013-10-10 Ala Wai Pharma, Inc. Formulations for enhanced bioavailability of orally administered polar agents
CN101538228B (zh) * 2008-03-21 2012-05-30 北京普世康医药技术有限公司 抗流感和禽流感病毒药物化合物帕拉米韦的合成方法
CN101486664B (zh) * 2008-12-31 2013-09-04 北京大学深圳研究生院 用作流感病毒神经氨酸酶抑制剂的多取代五元环小分子化合物
KR20120025519A (ko) 2009-05-15 2012-03-15 레드엑스 파마 리미티드 산화환원 약물 유도체
IT1396620B1 (it) 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
IN2012CN10271A (de) 2010-05-27 2015-04-10 Reddy’S Lab Ltd Dr
CN102584637B (zh) * 2011-01-17 2014-07-09 天津药物研究院 帕拉米韦水合物晶体、制备方法、药用组合物及其用途
CN102603577A (zh) * 2011-01-19 2012-07-25 董慧珍 一种抗流感和禽流感药物的衍生物及其用途
CN102757365B (zh) * 2011-04-29 2013-10-30 上海泓博智源医药技术有限公司 一种制备帕拉米韦关键中间体的方法
CN103827082B (zh) * 2011-04-29 2016-01-20 上海泓博智源医药技术有限公司 一种制备帕拉米韦及其中间体的新工艺
CN102964267B (zh) * 2011-09-01 2015-06-10 中山大学 一种具有流感病毒神经氨酸酶抑制活性的环己烯化合物及其制备方法以及其应用
CN102863359B (zh) * 2012-05-16 2014-05-07 常州制药厂有限公司 一种抗流感药物的合成方法
CN102702033A (zh) * 2012-06-11 2012-10-03 天津泰普药品科技发展有限公司 无定型帕拉米韦及其制备方法与药物组合物
US9227990B2 (en) 2012-10-29 2016-01-05 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
CN107056838A (zh) 2013-03-15 2017-08-18 加利福尼亚大学董事会 无环核苷膦酸二酯
JP6417568B2 (ja) * 2013-05-14 2018-11-07 バイオクリスト ファーマスーティカルズ，インコーポレイテッドＢｉｏｃｒｙｓｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 抗インフルエンザ組成物及び方法
CN105294589B (zh) * 2014-06-18 2017-06-30 朱靖华 一种抗病毒药物及其制备方法
EP3194411B1 (de) 2014-09-15 2022-05-04 The Regents of the University of California Nukleotidanaloga
CN104387288B (zh) * 2014-11-25 2016-04-20 广东东阳光药业有限公司 作为神经氨酸酶抑制剂的化合物及其在药物中的应用
CN104496839B (zh) * 2014-12-03 2016-04-20 广东东阳光药业有限公司 取代环丁烷类神经氨酸酶抑制剂及其使用方法和用途
CN104496838B (zh) * 2014-12-03 2016-04-20 广东东阳光药业有限公司 取代环丁烷类神经氨酸酶抑制剂及其使用方法和用途
CN104496857B (zh) * 2014-12-10 2016-10-12 广东东阳光药业有限公司 作为神经氨酸酶抑制剂的化合物及其在药物中的应用
CN105198827A (zh) * 2015-04-13 2015-12-30 广州南新制药有限公司 一种帕拉米韦中间体的合成方法
AU2016304862B2 (en) 2015-08-10 2021-02-18 Alzheon, Inc. Compositions and methods for treating and preventing neurodegenerative disorders
CN106220515A (zh) * 2016-08-12 2016-12-14 郸城巨鑫生物科技有限公司 一种(1r,4s)‑1‑氨基‑4‑羟甲基‑2‑环戊烯盐酸盐的合成方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT979736B (it) 1972-03-07 1974-09-30 Ethyl Corp Detersivo contenente un sequestran te e relativo metodo di impiego
US4089897A (en) * 1976-05-10 1978-05-16 Minnesota Mining And Manufacturing Company Geminal prostaglandin analogs
US4426391A (en) 1982-09-15 1984-01-17 Merck & Co., Inc. [(Alkoxycarbonyl)oxy]alkyl esters of methyldopa
JPS59163365A (ja) 1983-03-08 1984-09-14 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物
EP0130119B1 (de) 1983-06-23 1988-11-09 Merck & Co. Inc. (Acyloxyalkoxy)-carbonyl-Derivate als bioreversible Vorprodukte für Primär- und Sekundäramin-Funktionen in Arzneien, ihre Herstellung und pharmazeutische Produkte, die sie enthalten
ZA878096B (en) * 1986-11-03 1988-04-26 Merrell Dow Pharmaceuticals Inc. Esters of hexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one and related compounds
US4873019A (en) 1986-12-20 1989-10-10 Merck Patent Gesellschaft Mit Beschrankter Haftung Cyclopentane derivatives
WO1991011437A1 (en) * 1990-02-02 1991-08-08 Schering Corporation 4,5-cycloalkano-3-benzazepin-7-ol-derivatives and their use
WO1992016541A1 (en) 1991-03-12 1992-10-01 Mect Corporation Synthesis of sialic acid and synthetic intermediate therefor
JP2951765B2 (ja) 1991-09-10 1999-09-20 三共株式会社 エナミノエステル類およびその製法
AU673824B2 (en) * 1992-05-29 1996-11-28 Bayer Aktiengesellschaft Cyclopentane- and -pentene-beta-amino acids
JPH07145120A (ja) * 1993-11-25 1995-06-06 Kuraray Co Ltd ｃｉｓ−４−アミノ−２−シクロペンテン−１−カルボン酸の製造法
EP0746564B1 (de) * 1994-02-25 1998-12-02 E.I. Du Pont De Nemours And Company 4-n substituierte sialinsäuren und deren sialoside
US5453533A (en) * 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
US5789434A (en) 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
BR9607098B8 (pt) * 1995-02-27 2014-11-18 Gilead Sciences Inc Composto e composição farmacêutica.
CA2176414A1 (en) 1995-05-18 1996-11-19 S. David Kimball Acyl guanidine and amidine prodrugs
CN1184473A (zh) * 1995-05-19 1998-06-10 比奥塔科学管理有限公司 6－羟基酰胺－二氢吡喃衍生物
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
ES2263179T3 (es) * 1996-06-14 2006-12-01 Biocryst Pharmaceuticals Inc. Compuestos de clopentano sustituido como inhibidores de la neuraminidasa.
AU747293B2 (en) 1997-02-06 2002-05-16 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
EA003989B1 (ru) * 1997-09-17 2003-12-25 Джилид Сайэнс, Инк. Композиция (варианты) и способ лечения или профилактики инфекции гриппа у млекопитающего
RO121815B1 (ro) * 1997-12-17 2008-05-30 Biocryst Pharmaceuticals, Inc. Derivaţi pentaciclici substituiţi, compoziţie farmaceutică ce îi conţine şi utilizarea acestora ca inhibitori de neuraminidază
HUP0101224A3 (en) 1998-04-23 2002-12-28 Abbott Lab Pyrrolidine derivatives as inhibitors of neuraminidases and pharmaceutical compositions containing them
JP2002521312A (ja) 1998-04-23 2002-07-16 アボット・ラボラトリーズ ノイラミニダーゼの阻害剤

Also Published As

Publication number Publication date
CN1282316A (zh) 2001-01-31
NL300952I2 (nl) 2018-09-27
JP5709688B2 (ja) 2015-04-30
WO1999033781A1 (en) 1999-07-08
FR18C1037I2 (fr) 2019-06-21
PL341431A1 (en) 2001-04-09
FR18C1037I1 (fr) 2018-12-10
HUP0100142A2 (hu) 2001-05-28
LTPA2018513I1 (lt) 2018-10-10
JP2008163035A (ja) 2008-07-17
BR9813480A (pt) 2000-10-10
AU2200199A (en) 1999-07-19
JP4102022B2 (ja) 2008-06-18
NO20003084L (no) 2000-08-14
RO121815B1 (ro) 2008-05-30
EP1040094B1 (de) 2009-03-18
SI1040094T1 (sl) 2009-10-31
KR20010024743A (ko) 2001-03-26
PL196674B1 (pl) 2008-01-31
SK8712000A3 (en) 2000-11-07
PT1040094E (pt) 2009-06-03
HUP0100142A3 (en) 2002-01-28
BE2018C032I2 (de) 2018-10-15
ES2324746T3 (es) 2009-08-13
IL136812A0 (en) 2001-06-14
JP5118502B2 (ja) 2013-01-16
CY2018023I1 (el) 2018-12-12
ZA9811595B (en) 2000-06-19
DK1040094T3 (da) 2009-06-02
US6562861B1 (en) 2003-05-13
EP1040094A1 (de) 2000-10-04
NO20003084D0 (no) 2000-06-15
AR016162A1 (es) 2001-06-20
CY2018023I2 (el) 2018-12-12
JP2011256196A (ja) 2011-12-22
ATE425955T1 (de) 2009-04-15
LTC1040094I2 (lt) 2018-11-26
CA2315262C (en) 2009-11-10
EP1040094B9 (de) 2015-09-09
EP1040094A4 (de) 2004-12-08
CA2315262A1 (en) 1999-07-08
CY1109153T1 (el) 2014-07-02
JP2001527058A (ja) 2001-12-25

Similar Documents

Publication Publication Date Title
DE69840674D1 (de) Substituierte cyclopentan- und cyclopenten-verbindungen als neuraminidase-blocker
DE19882125T1 (de) Direkte Abscheidung von Palladium
DE69813616D1 (de) Cyclohexencarboxylate als inhibitoren der neuraminidase
ID23015A (id) Senyawa-senyawa anti radang
DE59810818D1 (de) Fügeverbindung
FI973847A0 (fi) Anordning vid en skyddsanordning
DE69817671D1 (de) Antragsrolle
DE59813430D1 (de) Perylenhydrazidimide als Carbonylderivatisierungsreagenzien
FR2759279B3 (fr) Ecran pare-douche
ATE532769T1 (de) 1-aryl-3-iminopyrazole als pestizide
DE69826125D1 (de) Fixiergerät
DE69826216D1 (de) Lärmschutz
FI970925A0 (fi) Anordning vid anestesianlaeggningar
FI972713A (fi) Näyttölaite
IT1303916B1 (it) Difenilammine nonilate
FI971744A0 (fi) Anordning vid cirkulationssmoerjningssystem
ID24343A (id) Perbaikan bagian-bagian struktural
DE69825927D1 (de) Fixiereinrichtung
DE29701251U1 (de) Säule
FI970798A0 (fi) List foer en avvattningsanordning i en pappersmaskin
ATA128198A (de) Dusche
DE29704434U1 (de) Türstopper
ATA200997A (de) Befestigungsbeschlag
DE29718629U1 (de) Pfeilerstein
NO985009D0 (no) Pillar

Legal Events

Date Code Title Description
R065 Request for grant of supplementary protection certificate validly filed

Free format text: PRODUCT NAME: PERAMIVIR UND PHARMAZEUTISCH AKZEPTABLE SALZE DAVON; REGISTRATION NO/DATE: EU/1/18/1269 20180413

Spc suppl protection certif: 122018000096

Filing date: 20180828

Expiry date: 20181218

Extension date: 20231217

R067 Examining division decision granting supplementary protection certificate

Free format text: PRODUCT NAME: PERAMIVIR UND PHARMAZEUTISCH AKZEPTABLE SALZE DAVON; REGISTRATION NO/DATE: EU/1/18/1269 20180413

Spc suppl protection certif: 122018000096

Filing date: 20180828

Expiry date: 20181218

Extension date: 20231217

R069 Supplementary protection certificate granted

Free format text: PRODUCT NAME: PERAMIVIR UND PHARMAZEUTISCH AKZEPTABLE SALZE DAVON; REGISTRATION NO/DATE: EU/1/18/1269 20180413

Spc suppl protection certif: 122018000096

Filing date: 20180828

Expiry date: 20181218

Extension date: 20231217